Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H23N |
Molecular Weight | 277.4033 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCC=C1C2=C(CCC3=C1C=CC=C3)C=CC=C2
InChI
InChIKey=KRMDCWKBEZIMAB-UHFFFAOYSA-N
InChI=1S/C20H23N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3
Molecular Formula | C20H23N |
Molecular Weight | 277.4033 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 18:01:32 UTC 2023
by
admin
on
Sat Dec 16 18:01:32 UTC 2023
|
Record UNII |
1806D8D52K
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
N06CA01
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
24.2.1
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
||
|
FDA ORPHAN DRUG |
288809
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
||
|
WHO-VATC |
QN06AA09
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
||
|
LIVERTOX |
NBK548410
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
||
|
NDF-RT |
N0000175752
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
||
|
FDA ORPHAN DRUG |
739620
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
8.4
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
||
|
NCI_THESAURUS |
C94727
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
||
|
WHO-VATC |
QN06CA01
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
||
|
WHO-ATC |
N06AA09
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
D000639
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY | |||
|
Amitriptyline
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY | |||
|
100000092029
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY | |||
|
AMITRIPTYLINE
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY | |||
|
3007
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY | |||
|
976
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY | |||
|
2160
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY | |||
|
200
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY | |||
|
50-48-6
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY | |||
|
SUB05462MIG
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY | |||
|
2666
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY | |||
|
m1753
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY | Merck Index | ||
|
C62005
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY | |||
|
704
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY | RxNorm | ||
|
CHEMBL629
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY | |||
|
1806D8D52K
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY | |||
|
DTXSID7022594
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY | |||
|
DB00321
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY | |||
|
180
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY | |||
|
1806D8D52K
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY | |||
|
200-041-6
Created by
admin on Sat Dec 16 18:01:35 UTC 2023 , Edited by admin on Sat Dec 16 18:01:35 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
Metabolizing reaction by CYP2D6: N-demethylation
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
BINDER->LIGAND |
BINDING
|
||
|
TARGET -> INHIBITOR | |||
|
TRANSPORTER -> INHIBITOR | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT | |||
|
TRANSPORTER -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> INHIBITOR |
IC50
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
TARGET -> INHIBITOR | |||
|
TARGET -> INHIBITOR | |||
|
BINDING PROTEIN->LIGAND |
Amitriptyline displayed an approximately 2:1 [drug:AGP] binding stoichiometry; DETERMINED BY ITC
BINDING
Kd
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE ACTIVE -> PARENT |
MAJOR
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
UNSPECIFIED
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
MAXIMUM TOLERATED DOSE | TOXICITY |
|
DEPRESSION, INPATIENTS: 300 MG/DAY |
|
||
Route of Elimination | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||